Your session is about to expire
← Back to Search
Spinal Bracing And Distraction System
Magnetic Growth Rods for Early-Onset Scoliosis (MCGR Trial)
N/A
Waitlist Available
Led By Michael Vitale, MD
Research Sponsored by Pediatric Spine Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All patients with diagnosis of Early Onset Scoliosis (scoliosis before age 10)
Dual-rod Magnetically Controlled Growing Rod implantation only
Must not have
Patients with previous spine surgery, including other growth friendly techniques and all previous neurosurgical procedures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will study whether 6-week or 16-week intervals are better for spinal growth in Early Onset Scoliosis patients 5-9 years old.
Who is the study for?
This trial is for children aged 5 to 9 with Early Onset Scoliosis and a major spinal curve over 50 degrees. They must be first-time patients for spine surgery, able to follow the study plan, and have dual-rod Magnetically Controlled Growing Rods implanted.
What is being tested?
The study compares two different lengthening intervals (6 weeks vs. 16 weeks) of the MAGEC® Spinal Bracing And Distraction System in managing scoliosis in young patients, observing spinal growth outcomes over three years.
What are the potential side effects?
Potential side effects may include discomfort at the rod site, possible infection risk due to repeated adjustments, or issues related to improper bone growth or alignment from the bracing system.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was diagnosed with scoliosis before I turned 10.
Select...
I have a dual-rod magnetically controlled growing rod implant.
Select...
I am between 5 and 9 years old.
Select...
My spine's major curve was over 50 degrees when I had my first surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had spine surgery or any neurosurgical procedures before.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Spinal growth
Secondary study objectives
Burden of care
Complications
Curve correction
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 6 weeksExperimental Treatment1 Intervention
6-week lengthening interval
Group II: 16 weeksActive Control1 Intervention
16-week lengthening interval
Find a Location
Who is running the clinical trial?
Pediatric Spine FoundationLead Sponsor
1 Previous Clinical Trials
106 Total Patients Enrolled
Columbia UniversityOTHER
1,486 Previous Clinical Trials
2,662,980 Total Patients Enrolled
Michael Vitale, MDPrincipal InvestigatorColumbia University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had spine surgery or any neurosurgical procedures before.I was diagnosed with scoliosis before I turned 10.I have a dual-rod magnetically controlled growing rod implant.You have had a surgery that involved placing metal rods or plates in your spine or ribs.I am between 5 and 9 years old.My spine's major curve was over 50 degrees when I had my first surgery.I am allowed to have halo gravity traction before and during surgery.
Research Study Groups:
This trial has the following groups:- Group 1: 16 weeks
- Group 2: 6 weeks
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger